Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · CellCept

CellCept 1 g/5 ml powder for oral suspension · Abschnitt 4.8 · PDF-Seite 58–59

HOS-085371 · Präparat HOS-083095

58 Similar observations were made in another clinical trial, which recruited 100 paediatric renal transplant patients aged 1 to 18 years. The type and frequency of adverse reactions in patients who were given 600 mg/m2, up to 1 g/m2 of mycophenolate mofetil orally, twice daily, were comparable to those observed in adult patients given 1 g mycophenolate mofetil twice daily. A summary of the more frequently occurring adverse reactions is shown in table 3 below:

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.